Boothbay Fund Management’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,680
| Closed | -$29.6K | – | 1434 |
|
|
2025
Q1 | $29.6K | Hold |
4,680
| – | – | ﹤0.01% | 1141 |
|
|
2024
Q4 | $48.3K | Buy |
4,680
+27
| +0.6% | +$279 | ﹤0.01% | 1194 |
|
|
2024
Q3 | $59.8K | Hold |
4,653
| – | – | ﹤0.01% | 1305 |
|
|
2024
Q2 | $64.4K | Hold |
4,653
| – | – | ﹤0.01% | 1229 |
|
|
2024
Q1 | $1.45M | Sell |
4,653
-346
| -7% | -$108K | 0.03% | 523 |
|
|
2023
Q4 | $1.31M | Buy |
4,999
+319
| +7% | +$83.6K | 0.03% | 535 |
|
|
2023
Q3 | $915K | Buy |
4,680
+1,406
| +43% | +$275K | 0.02% | 666 |
|
|
2023
Q2 | $673K | Buy |
3,274
+2,580
| +372% | +$530K | 0.01% | 814 |
|
|
2023
Q1 | $69.8K | Hold |
694
| – | – | ﹤0.01% | 1747 |
|
|
2022
Q4 | $109K | Hold |
694
| – | – | ﹤0.01% | 1519 |
|
|
2022
Q3 | $174K | Sell |
694
-73
| -10% | -$18.3K | ﹤0.01% | 1615 |
|
|
2022
Q2 | $217K | Sell |
767
-3
| -0.4% | -$849 | 0.01% | 1442 |
|
|
2022
Q1 | $155K | Hold |
770
| – | – | ﹤0.01% | 1594 |
|
|
2021
Q4 | $168K | Sell |
770
-14
| -2% | -$3.06K | ﹤0.01% | 1382 |
|
|
2021
Q3 | $358K | Sell |
784
-879
| -53% | -$401K | 0.01% | 1036 |
|
|
2021
Q2 | $668K | Sell |
1,663
-10
| -0.6% | -$4.02K | 0.02% | 754 |
|
|
2021
Q1 | $970K | Sell |
1,673
-74
| -4% | -$42.9K | 0.04% | 494 |
|
|
2020
Q4 | $996K | Buy |
1,747
+874
| +100% | +$498K | 0.04% | 407 |
|
|
2020
Q3 | $488K | Buy |
+873
| New | +$488K | 0.03% | 553 |
|